Maximum quantity allowed is 999
请选择数量
CAS RN: 123524-52-7 | 產品號碼: A2433
Azelnidipine

纯度/分析方法: >98.0%(T)(HPLC)
別名
- 2-Amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[1-(Diphenylmethyl)-3-azetidinyl] 5-Isopropyl Ester
- 3-[1-(Diphenylmethyl)-3-azetidinyl] 5-Isopropyl 2-Amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
文件:
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | A2433 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__3__3H__3__4N__4O__6 = 582.66 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Air Sensitive |
包裝和容器 | 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 123524-52-7 |
Reaxys-RN | 7420123 |
PubChem Substance ID | 253661997 |
Merck Index(14) | 907 |
MDL編號 | MFCD00865803 |
產品規格
Appearance | Light orange to Yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
性質
水溶性 | Insoluble |
溶解性(可溶於) | Methanol, Ethanol |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H302 : Harmful if swallowed. H413 : May cause long lasting harmful effects to aquatic life. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
RTECS # | US7968332 |
運輸資料
HS編碼* | 2933.99-000 |
Application
Azelnidipine: An L-type Calcium Channels Selective Calcium Channel Antagonist
Azelnidipine, also known as CS-905, is a long-acting dihydropyridine calcium channel antagonist with selectivity for L-type calcium channels for the treatment of hypertension. (The product is for research purpose only.)
References
- Azelnidipine (a review)
- Azelnidipine, a long-acting calcium channel blocker with slow onset and high vascular affinity (a review)
- H. Koike, T. Kimura, T. Kawasaki, T. Sada, T. Ikeda, A. Sanbuissho, H. Saito, Annu. Rep. Sankyo Res. Lab. 2003, 54, 1.
- Azelnidipine and amlodipine [A2353]: a comparison of their pharmacokinetics and effects on ambulatory blood pressure
- Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan
- Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties
- Spectroscopic studies on the interaction of azelnidipine with bovine serum albumin
考研文獻
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。